Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 1375

1.

Infection and Stroke: an Update on Recent Progress.

Miller EC, Elkind MS.

Curr Neurol Neurosci Rep. 2016 Jan;16(1):2. doi: 10.1007/s11910-015-0602-9. Review.

PMID:
26677196
2.

Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized Trials.

Ayele HT, Mourik MS, Debray TP, Bonten MJ.

PLoS One. 2015 Nov 9;10(11):e0142290. doi: 10.1371/journal.pone.0142290. eCollection 2015. Review.

3.
4.

Implementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy.

van Griensven J, Choun K, Chim B, Thai S, Lorent N, Lynen L.

Trop Med Int Health. 2015 Dec;20(12):1823-31. doi: 10.1111/tmi.12609. Epub 2015 Oct 19.

PMID:
26426387
5.

HIV-Specific Antibody Responses in HIV-Infected Patients: From a Monoclonal to a Polyclonal View.

Gallerano D, Cabauatan CR, Sibanda EN, Valenta R.

Int Arch Allergy Immunol. 2015;167(4):223-41. doi: 10.1159/000438484. Epub 2015 Sep 29. Review.

6.

Pharmacotherapeutic aspect of antibiotic therapy during acute community-acquired pneumonia in adults at the University Hospital of Cocody (Abidjan).

Kouakou-Siransy G, Horo K, Effo E, Kamenan A, N'guessan-IriƩ G, Boko-Kouassi A, Aka-Anguy E, Die Kakou H.

Int J Clin Pharmacol Ther. 2015 Nov;53(11):940-6. doi: 10.5414/CP202349.

PMID:
26413732
7.

A Multiple siRNA-Based Anti-HIV/SHIV Microbicide Shows Protection in Both In Vitro and In Vivo Models.

Boyapalle S, Xu W, Raulji P, Mohapatra S, Mohapatra SS.

PLoS One. 2015 Sep 25;10(9):e0135288. doi: 10.1371/journal.pone.0135288. eCollection 2015.

8.

A Systematic Review of the Inclusion (or Exclusion) of Women in HIV Research: From Clinical Studies of Antiretrovirals and Vaccines to Cure Strategies.

Curno MJ, Rossi S, Hodges-Mameletzis I, Johnston R, Price MA, Heidari S.

J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):181-8. doi: 10.1097/QAI.0000000000000842. Review.

PMID:
26361171
9.

Thermosensitive Gel Containing Cellulose Acetate Phthalate-Efavirenz Combination Nanoparticles for Prevention of HIV-1 Infection.

Date AA, Shibata A, McMullen E, La Bruzzo K, Bruck P, Belshan M, Zhou Y, Destache CJ.

J Biomed Nanotechnol. 2015 Mar;11(3):416-27.

PMID:
26307825
10.

Stevens Johnson Syndrome and Toxic Epidermal Necrolysis: Maternal and Foetal Outcomes in Twenty-Two Consecutive Pregnant HIV Infected Women.

Knight L, Todd G, Muloiwa R, Matjila M, Lehloenya RJ.

PLoS One. 2015 Aug 12;10(8):e0135501. doi: 10.1371/journal.pone.0135501. eCollection 2015.

11.

Updated analysis: central venous access device infection rates in an expanded cohort of paediatric patients with severe haemophilia receiving prophylactic recombinant tissue plasminogen activator.

McCarthy CE, O'Brien M, Andrews J, Zoland JM, Macasiray E, Wong W, Lo C, Glader B, Tamaresis J, Jeng M.

Haemophilia. 2016 Jan;22(1):81-6. doi: 10.1111/hae.12772. Epub 2015 Aug 7.

PMID:
26248602
12.

Is hepatitis E virus an emerging problem in industrialized countries?

Sayed IM, Vercouter AS, Abdelwahab SF, Vercauteren K, Meuleman P.

Hepatology. 2015 Dec;62(6):1883-92. doi: 10.1002/hep.27990. Epub 2015 Aug 28. Review.

PMID:
26175182
13.

Regulatory challenges in developing long-acting antiretrovirals for treatment and prevention of HIV infection.

Arya V, Au S, Belew Y, Miele P, Struble K.

Curr Opin HIV AIDS. 2015 Jul;10(4):278-81. doi: 10.1097/COH.0000000000000163.

PMID:
26049954
14.

Antibody responses to envelope glycoproteins in HIV-1 infection.

Burton DR, Mascola JR.

Nat Immunol. 2015 Jun;16(6):571-6. doi: 10.1038/ni.3158. Review.

15.

Antibiotics prescription in Nigerian dental healthcare services.

Azodo CC, Ojehanon PI.

Odontostomatol Trop. 2014 Sep;37(147):34-42.

PMID:
25975066
16.

Adenovirus-Vectored Broadly Neutralizing Antibodies Directed Against gp120 Prevent Human Immunodeficiency Virus Type 1 Acquisition in Humanized Mice.

Liu S, Jackson A, Beloor J, Kumar P, Sutton RE.

Hum Gene Ther. 2015 Sep;26(9):622-34. doi: 10.1089/hum.2014.146. Epub 2015 Aug 11.

PMID:
25953321
17.

Nontuberculous mycobacterial osteomyelitis.

Bi S, Hu FS, Yu HY, Xu KJ, Zheng BW, Ji ZK, Li JJ, Deng M, Hu HY, Sheng JF.

Infect Dis (Lond). 2015;47(10):673-85. doi: 10.3109/23744235.2015.1040445. Epub 2015 Apr 27. Review.

18.

Evaluation of adherence measures of antiretroviral prophylaxis in HIV exposed infants in the first 6 weeks of life.

Desmond AC, Moodley D, Conolly CA, Castel SA, Coovadia HM.

BMC Pediatr. 2015 Mar 19;15:23. doi: 10.1186/s12887-015-0340-9.

19.

HIV vaccine research: the challenge and the way forward.

Wang HB, Mo QH, Yang Z.

J Immunol Res. 2015;2015:503978. doi: 10.1155/2015/503978. Epub 2015 Mar 15. Review.

20.

[HPV-induced anal lesions].

Wieland U, Kreuter A.

Hautarzt. 2015 Jun;66(6):439-45. doi: 10.1007/s00105-015-3630-0. Review. German.

PMID:
25859930
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk